-+ 0.00%
-+ 0.00%
-+ 0.00%

EXDENSUR (DEPEMOKIMAB) APPROVED BY US FDA FOR THE TREATMENT OF SEVERE ASTHMA

Reuters·12/17/2025 02:55:00

Please log in to view news